SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001387131-21-002348
Filing Date
2021-02-16
Accepted
2021-02-12 21:35:24
Documents
2
Group Members
ALTIUM CAPITAL MANAGEMENT, LPALTIUM GROWTH FUND, LPALTIUM GROWTH GP, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SC 13G adtx-sc13ga_021221.htm SC 13G/A 96544
2 JOINT ACQUISITION STATEMENT ex-1.htm EX-1 10055
  Complete submission text file 0001387131-21-002348.txt   108293
Mailing Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043
Business Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043 909-488-0844
Aditx Therapeutics, Inc. (Subject) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91561 | Film No.: 21631579
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 W 57 ST FL20 NEW YORK NY 10019
Business Address 152 W 57 ST FL20 NEW YORK NY 10019 2124842711
Altium Capital Management LP (Filed by) CIK: 0001746382 (see all company filings)

IRS No.: 822066653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A